Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy. [electronic resource]
- International journal of molecular sciences Jun 2017
Publication Type: Journal Article; Review
1422-0067
10.3390/ijms18061234 doi
Animals Antineoplastic Agents--pharmacology Antineoplastic Combined Chemotherapy Protocols--therapeutic use Humans Molecular Targeted Therapy Neoplasms--drug therapy Phosphorylation Protein Tyrosine Phosphatase, Non-Receptor Type 6--antagonists & inhibitors STAT3 Transcription Factor--metabolism Signal Transduction--drug effects